Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Claudel

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|March 7, 2020
Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in miceClaudia D Fuchs, Sebastian Krivanec, Daniel Steinacher, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ outputAnna Baghdasaryan, Thierry Claudel, Judith Gumhold, et al.
The Journal of Clinical Investigation|April 3, 2002
Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response elementThierry Claudel, Ekkehard Sturm, Hélène Duez, et al.
Journal of Hepatology|January 25, 2015
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesityMichaela Mueller, Anders Thorell, Thierry Claudel, et al.
Hepatology (Baltimore, Md.)|January 25, 2012
Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in miceClaudia D Fuchs, Thierry Claudel, Pooja Kumari, et al.
Atherosclerosis|September 29, 2009
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatmentTatjana Stojakovic, Thierry Claudel, Csilla Putz-Bankuti, et al.
Biochimica Et Biophysica Acta|May 1, 2013
The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolismJianfeng Huang, Suman Kumar Das, Pooja Jha, et al.
International Journal of Molecular Sciences|March 6, 2021
Absence of Adiponutrin (PNPLA3) and Monoacylglycerol Lipase Synergistically Increases Weight Gain and Aggravates Steatohepatitis in MiceMatteo Tardelli, Francesca V Bruschi, Claudia D Fuchs, et al.
Hepatology Communications|January 16, 2026
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytesLaura Valestrand, Kathrine S Nordhus, Thierry Claudel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 14, 2020
Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinomaAlexander D Nardo, Nicole G Grün, Maximilian Zeyda, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Liver International : Official Journal of the International Association for the Study of the Liver|March 7, 2020
Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in miceClaudia D Fuchs, Sebastian Krivanec, Daniel Steinacher, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ outputAnna Baghdasaryan, Thierry Claudel, Judith Gumhold, et al.
The Journal of Clinical Investigation|April 3, 2002
Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response elementThierry Claudel, Ekkehard Sturm, Hélène Duez, et al.
Journal of Hepatology|January 25, 2015
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesityMichaela Mueller, Anders Thorell, Thierry Claudel, et al.
Hepatology (Baltimore, Md.)|January 25, 2012
Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in miceClaudia D Fuchs, Thierry Claudel, Pooja Kumari, et al.
Atherosclerosis|September 29, 2009
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatmentTatjana Stojakovic, Thierry Claudel, Csilla Putz-Bankuti, et al.
Biochimica Et Biophysica Acta|May 1, 2013
The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolismJianfeng Huang, Suman Kumar Das, Pooja Jha, et al.
International Journal of Molecular Sciences|March 6, 2021
Absence of Adiponutrin (PNPLA3) and Monoacylglycerol Lipase Synergistically Increases Weight Gain and Aggravates Steatohepatitis in MiceMatteo Tardelli, Francesca V Bruschi, Claudia D Fuchs, et al.
Hepatology Communications|January 16, 2026
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytesLaura Valestrand, Kathrine S Nordhus, Thierry Claudel, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 14, 2020
Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinomaAlexander D Nardo, Nicole G Grün, Maximilian Zeyda, et al.
Pageof 7